Related references
Note: Only part of the references are listed.Developing and validating natural language processing algorithms for radiology reports compared to ICD-10 codes for identifying venous thromboembolism in hospitalized medical patients
Amol A. Verma et al.
THROMBOSIS RESEARCH (2022)
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer
Anna Falanga et al.
HEMASPHERE (2022)
The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies
Jaime L. Shaw et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
Venous thromboembolism in cancer patients: a population-based cohort study
F. Mulder et al.
BLOOD (2021)
Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study
Brian J. Carney et al.
BLOOD ADVANCES (2021)
Validation of an electronic algorithm for Hodgkin and non-Hodgkin lymphoma in ICD-10-CM
Mara M. Epstein et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2021)
Occurrence and Management of Thrombocytopenia in Metastatic Colorectal Cancer Patients Receiving Chemotherapy: Secondary Analysis of Data From Prospective Clinical Trials
Karynsa Kilpatrick et al.
CLINICAL COLORECTAL CANCER (2021)
Venous Thromboembolism in Pediatric Cancer Patients with Central Venous Catheter-A Systematic Review and Meta-analysis
Rasmus Sogaard Hansen et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2021)
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial
Robert D. McBane et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Chemotherapy-induced thrombocytopenia and platelet transfusion in patients with diffuse large B-cell lymphoma
Rong Lu et al.
TRANSLATIONAL CANCER RESEARCH (2020)
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Pulmonary embolism during the COVID-19 pandemic: Decline in diagnostic procedures and incidence at a university hospital
Stephan Nopp et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
Validation of an Algorithm for Claims-based Incidence of Prostate Cancer
Lauren E. Parlett et al.
EPIDEMIOLOGY (2019)
Development of thrombocytopenia during first-line treatment and survival outcomes in newly diagnosed multiple myeloma
Patrick W. Mellors et al.
LEUKEMIA & LYMPHOMA (2019)
Immunotherapy and targeted therapy-the new roadmap in cancer treatment
Kamran Shahid et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
Viola Poeschel et al.
LANCET (2019)
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
Annie M. Young et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Chart validation of inpatient International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) administrative diagnosis codes for venous thromboembolism (VTE) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database
Eric M. Ammann et al.
MEDICINE (2018)
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Gary E. Raskob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Sensitivity and specificity of breast cancer ICD-9-CM codes in three Italian administrative healthcare databases: a diagnostic accuracy study
Iosief Abraha et al.
BMJ OPEN (2018)
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
John P. Neoptolemos et al.
LANCET (2017)
Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism
Julia Riedl et al.
BLOOD (2017)
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial
G. Agnelli et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study
Ilana Kopolovic et al.
ANNALS OF HEMATOLOGY (2015)
Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group
Noelia Purroy et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer The CONKO-001 Randomized Trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma
Shaji Kumar et al.
BLOOD (2012)
A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data
Leonardo Tamariz et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis
Freesia Horsted et al.
PLOS MEDICINE (2012)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
Paul G. Richardson et al.
BLOOD (2010)
Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters
Ha Tran et al.
LEUKEMIA & LYMPHOMA (2010)
Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States
Richard H. White et al.
THROMBOSIS RESEARCH (2010)
The Incidence and Risk of Venous Thromboembolism Associated With Cancer and Nonsurgical Cancer Treatment
Anna Falanga
CANCER INVESTIGATION (2009)
A high positive predictive value algorithm using hospital administrative data identified incident cancer cases
Ileana Baldi et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Alok A. Khorana et al.
CANCER (2007)
Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry data
Soko Setoguchi et al.
CANCER CAUSES & CONTROL (2007)
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
A. A. Khorana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Incidence of venous thrombosis in a large cohort of 66 329 cancer patients:: results of a record linkage study
JW Blom et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
AYY Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)